Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
NHS Blood & Transplant
500-600 North Bristol Park, Northway Bristol, Filton
BRISTOL
BS347QH
UK
Contact person: Marta Drozdzowska
Telephone: +44 1179217243
E-mail: marta.drozdzowska@nhsbt.nhs.uk
NUTS: UK
Internet address(es)
Main address: https://www.nhsbt.nhs.uk/
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis
Reference number: NHSBT1498 / C39526
II.1.2) Main CPV code
33140000
II.1.3) Type of contract
Supplies
II.1.4) Short description
The award is for Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis.
Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004887.
Please see section II.2.4 for detailed description of the procurement.
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
99 500.00
GBP
II.2) Description
II.2.2) Additional CPV code(s)
33693000
50421000
II.2.3) Place of performance
NUTS code:
UK
II.2.4) Description of the procurement
The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Treatments provided include: Extracorporeal Photopheresis (ECP), Peripheral Blood Stem Cell (PBSC) Collection, Therapeutic Plasma Exchange (PEX), Red Cell Exchange (RCE), Low Density Lipid (LDL) Removal, Platelet / White Cell Depletion and Lymphocyte Collection.
The requirement for this procurement was for the supply of consumables and maintenance of the existing ART Universal machines. Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004887.
As a result of the tender, a Framework Agreement for Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis for a period of 2 years with two 1-year options to extend has been awarded to Fresenius Medical Care (UK) Ltd.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2020/S 230-568414
Section V: Award of contract
Contract No: NHSBT1498 / C39526
Title: Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
01/08/2021
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Fresenius Medical Care (UK) Ltd
Sutton-in-Ashfield
NG17 2HU
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 99 500.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.4) Procedures for review
VI.4.1) Review body
NHS Blood and Transplant
Bristol
UK
VI.5) Date of dispatch of this notice
11/08/2021